1. Home
  2. PLRX vs DDI Comparison

PLRX vs DDI Comparison

Compare PLRX & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • DDI
  • Stock Information
  • Founded
  • PLRX 2015
  • DDI 2008
  • Country
  • PLRX United States
  • DDI South Korea
  • Employees
  • PLRX N/A
  • DDI N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • DDI EDP Services
  • Sector
  • PLRX Health Care
  • DDI Technology
  • Exchange
  • PLRX Nasdaq
  • DDI Nasdaq
  • Market Cap
  • PLRX 641.5M
  • DDI 769.1M
  • IPO Year
  • PLRX 2020
  • DDI 2021
  • Fundamental
  • Price
  • PLRX $14.72
  • DDI $10.96
  • Analyst Decision
  • PLRX Strong Buy
  • DDI Strong Buy
  • Analyst Count
  • PLRX 7
  • DDI 3
  • Target Price
  • PLRX $40.50
  • DDI $22.67
  • AVG Volume (30 Days)
  • PLRX 459.1K
  • DDI 54.3K
  • Earning Date
  • PLRX 11-07-2024
  • DDI 02-11-2025
  • Dividend Yield
  • PLRX N/A
  • DDI N/A
  • EPS Growth
  • PLRX N/A
  • DDI N/A
  • EPS
  • PLRX N/A
  • DDI 2.30
  • Revenue
  • PLRX N/A
  • DDI $342,458,000.00
  • Revenue This Year
  • PLRX N/A
  • DDI N/A
  • Revenue Next Year
  • PLRX N/A
  • DDI $1.30
  • P/E Ratio
  • PLRX N/A
  • DDI $4.97
  • Revenue Growth
  • PLRX N/A
  • DDI 13.42
  • 52 Week Low
  • PLRX $10.22
  • DDI $7.16
  • 52 Week High
  • PLRX $19.62
  • DDI $18.21
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 56.15
  • DDI 31.14
  • Support Level
  • PLRX $13.14
  • DDI $11.02
  • Resistance Level
  • PLRX $15.27
  • DDI $12.65
  • Average True Range (ATR)
  • PLRX 0.75
  • DDI 0.85
  • MACD
  • PLRX 0.00
  • DDI -0.21
  • Stochastic Oscillator
  • PLRX 58.27
  • DDI 11.99

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. Its market opportunity includes casual gaming globally, which includes slots, puzzles, cards, match three, and other similar games. Within the social casino segment of casual gaming, which includes free-to-play online slots, poker, table games, and bingo. Other games developed by the company are DoubleDown Fort, DoubleDown Classic, and Ellen's Road to Riches. The company has a presence in the international market, and it derives a majority of its revenue from the United States of America.

Share on Social Networks: